| Drug Name: | Nafenopin (3771-19-5) |
|---|---|
| PubChem ID: | 19592 |
| SMILES: | CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23 |
| InchiKey: | XJGBDJOMWKAZJS-UHFFFAOYSA-N |
| Therapeutic Category: | Antimetabolites, Carcinogens, Hypolipidemic Agents, Lipid Regulating Agents, Noxae, Peroxisome Proliferators |
| Molecular Weight (dalton) | : | 310.393 |
| LogP | : | 4.3968 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 46.53 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category